Dr. Jason Goodchild, Vice President of Clinical Affairs at Premier Dental Products Company, and Dr. Mark Donaldson, Associate Principal in Pharmacy Advisory Solutions at Vizient discuss the merits of a recent statement on antibiotic prophylaxis for infective endocarditis with host Gretchen Brummel.

Guest speakers:

Jason Goodchild, DMD

Vice President of Clinical Affairs

Premier Dental Products Company

Mark Donaldson, BSP, ACPR, PHARMD, FASHP, FACHE

Associate Principal, Pharmacy Advisory Solutions

Vizient

Moderator:

Gretchen Brummel, PharmD, BCPS

Pharmacy Executive Director

Vizient Center for Pharmacy Practice Excellence

Show Notes:

[00:53-1:55] Antibiotic prophylaxis against infective endocarditis as an important tool

[01:56-2:48] Risks of over- or underutilization of this treatment modality

[02:49-4:52] History of the guidelines

[04:53-5:48] New statement impacts moving forward

[05:49-8:49] Doxycycline as alternative to clindamycin in penicillin-allergic patients

[08:50-9:47] The rationale to abandon clindamycin

[09:48-11:49] How clindamycin compares to other agents

[11:50-12:59] The bottom line

Links | Resources:

Prevention of Viridans group Streptococcal infective endocarditis: a scientific statement from the American Heart Association: Click here

Prevention of infective endocarditis: guidelines from the American Heart Association: Click here

Antibiotic prophylaxis guidelines: is there new information for 2021? Click here

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed